Shalini Sharp
Director at Septerna, Inc. (SEPN)
Shalini Sharp has filed 30 insider reports with the SEC since February 2021, as director at Septerna, Inc. (SEPN), director at BeOne Medicines Ltd. (ONC) and director at Organon & Co. (OGN) and at 5 more companies. Shalini Sharp made no open-market purchases or sales in the last 12 months. The latest filing, on June 30, 2026, reports grant or award at Septerna, Inc. (SEPN).
- Filings
- 30
- Companies
- 8
- Bought on market
- None
- Sold on market
- $157K
Companies where Shalini Sharp is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | $39.45 | Jun 30, 2026 | |||||
| Directorsince September 2024 | 38,116 | $403.60 | Jun 15, 2026 | ||||
| Director | 2 | $13.92 | Jun 15, 2026 | ||||
| Director | 4,088 | $157K | $162.86 | May 29, 2026 | |||
| Directorsince March 2021 | 0 | Jan 24, 2024 | |||||
| Director | $8.50 | Jun 8, 2022 | |||||
| Director | $7.10 | May 12, 2021 | |||||
| Director | 35,000 | $3.78 | Feb 27, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 26, 2026SEPNSEC Form 4 filed by Director Sharp ShaliniForm 4Grant or award
- Jun 11, 2026ONCDirector Sharp Shalini was granted 18,980 units of Ordinary Shares, increasing direct ownership by 99% to 38,116 unitsForm 4Grant or award
- Jun 12, 2026OGNSEC Form 4 filed by Director Sharp ShaliniForm 4Grant or award
- May 27, 2026NBIXSEC Form 4 filed by Director Sharp ShaliniForm 4Grant or award
- May 21, 2026NBIXDirector Sharp Shalini converted options into 1,659 shares, increasing direct ownership by 68% to 4,088 unitsForm 4Exercise or conversion of a derivative
- Sep 27, 2024ONCAmendment: New insider Sharp Shalini claimed ownership of 9 units of American Depositary SharesForm 3/ANew insider
- Jun 17, 2025SEPNSEC Form 4 filed by Director Sharp ShaliniForm 4Grant or award
- Jun 13, 2025OGNSEC Form 4 filed by Director Sharp ShaliniForm 4Grant or award
- May 21, 2025ONCDirector Sharp Shalini was granted 10,985 units of Ordinary Shares, increasing direct ownership by 135% to 19,136 unitsForm 4Grant or award
- May 22, 2025NBIXDirector Sharp Shalini converted options into 1,435 shares, increasing direct ownership by 144% to 2,429 unitsForm 4Grant or awardExercise or conversion of a derivative
- Sep 30, 2024ONCDirector Sharp Shalini was granted 8,151 units of Ordinary SharesForm 4Grant or award
- Sep 27, 2024ONCShalini Sharp became an insiderForm 3New insider
- Jun 7, 2024OGNSEC Form 4 filed by Director Sharp ShaliniForm 4Grant or award
- May 22, 2024NBIXSEC Form 4 filed by Sharp ShaliniForm 4Grant or award
- May 17, 2024-$157KNBIXSharp Shalini converted options into 2,100 shares and sold $156,943 worth of shares (1,106 units at $141.90)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jan 23, 2024MRTXSharp Shalini returned 16,222 shares to the company, closing all direct ownership in the companyForm 4Sale back to the company
- Dec 29, 2023MRTXSharp Shalini was granted 6,808 shares, increasing direct ownership by 72% to 16,222 unitsForm 4Grant or award
- Jun 9, 2023OGNSEC Form 4 filed by Sharp ShaliniForm 4Grant or award
- May 17, 2023NBIXSEC Form 4 filed by Sharp ShaliniForm 4Grant or award
- Jan 20, 2023MRTXSEC Form 4: Sharp Shalini was granted 4,444 shares, increasing direct ownership by 89% to 9,414 unitsForm 4Grant or award
- Jun 10, 2022OGNSEC Form 4 filed by Sharp ShaliniForm 4Grant or award
- Jun 6, 2022STROSEC Form 4 filed by Sharp ShaliniForm 4Grant or award
- May 18, 2022NBIXSEC Form 4 filed by Sharp ShaliniForm 4Grant or award
- Jan 14, 2022MRTXSEC Form 4: Sharp Shalini was granted 2,546 shares, increasing direct ownership by 105% to 4,970 unitsForm 4Grant or award
- Jun 4, 2021OGNSEC Form 4 filed by Sharp ShaliniForm 4Grant or award
- Jun 3, 2021STROSEC Form 4 filed by Sharp ShaliniForm 4Grant or award
- May 10, 2021DTILSEC Form 4 filed by Sharp ShaliniForm 4Grant or award
- Mar 26, 2021MRTXSEC Form 3: Shalini Sharp claimed no ownership of Common StockForm 3New insider
- Mar 26, 2021MRTXSEC Form 4: Shalini Sharp was granted 2,424 units of Common StockForm 4Grant or award
- Feb 10, 2021NUVBSEC Form 4: Shalini Sharp exercised 25,000 units of Class A Common Stock at a strike of $0.00 and was granted 10,000 units of Class A Common StockForm 4Grant or awardExercise or conversion of a derivative
Also sits on boards with
Officers and directors who share two or more companies with Shalini Sharp.
Compare Shalini Sharp with
- Shalini Sharp vs Alan Ezekowitz2 shared
- Shalini Sharp vs Faheem Hasnain2 shared
- Shalini Sharp vs Gil M Labrucherie1 shared
- Shalini Sharp vs Jeffrey Finer1 shared
- Shalini Sharp vs Juliana Papa Drinane1 shared
- Shalini Sharp vs Joseph T. Morrissey Jr.1 shared
Other insiders at the same companies
- Gil M LabrucherieSEPN
- Jeffrey FinerSEPN
- Juliana Papa DrinaneOGN
- Joseph T. Morrissey Jr.OGN
- Samsara BioCapital, L.P.SEPN
- Xiaodong WangONC
- Dario ScimecaDTIL
- Titus B. BallONC
- Arjona Ferreira Juan CamiloOGN
- Lynette HolzbaurOGN
- Chan Henry LeeONC
- Eiry RobertsNBIX
- George J MorrowNBIX
- Kyle GanoNBIX
- Stanley FrankelDTIL
Questions about Shalini Sharp
- What is Shalini Sharp's role at Septerna, Inc.?
- Shalini Sharp reports to the SEC as director at Septerna, Inc. (SEPN), according to the latest filing on June 30, 2026. Shalini Sharp has also filed as director at BeOne Medicines Ltd. (ONC), director at Organon & Co. (OGN), director at Neurocrine Biosciences Inc (NBIX) and director at Mirati Therapeutics, Inc. (MRTX).
- How many shares does Shalini Sharp own?
- After the latest filing that states it, Shalini Sharp directly owned 38,116 shares of BeOne Medicines Ltd. (ONC), 2 shares of Organon & Co. (OGN), 4,088 shares of Neurocrine Biosciences Inc (NBIX) and 35,000 shares of Nuvation Bio Inc. (NUVB). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Shalini Sharp bought or sold stock recently?
- The most recent open-market sale was on May 17, 2024: sold 1,106 shares of Neurocrine Biosciences Inc (NBIX) for $157K at an average of $141.90.
- How do I get alerts when Shalini Sharp files?
- Follow Shalini Sharp on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Shalini Sharp (SEC CIK 0001377202). Totals count each trade once, skipping amendments whose original is on file, from Feb 27, 2021 on. View on SEC EDGAR